Pintu Kanjilal
Scientist, LNP Discovery, Strand Therapeutics
Pintu Kanjilal is a formulation scientist specializing in lipid nanoparticles and targeted nanomedicine for mRNA therapeutics. At Strand Therapeutics, he develops and optimizes LNP systems for improved delivery and tumor-specific expression. His background spans polymer chemistry, bioconjugation, and drug delivery, with a PhD from UMass Amherst focused on nanoparticle-based targeting strategies.
